RBM46 and teratocarcinoma: In addition, FACS analysis showed that the percentage of SSEA1 positive cells was higher in the control group than in the Rbm46 shRNA group (65.05% vs 49.82) (Fig 3C), and teratocarcinoma formed by Rbm46-silenced cells were much smaller in size and weight than those formed by the control cells (Fig 3D).